How much does Trastuzumab injection (subcutaneous injection) (Herceptin Hylecta) cost?

Trastuzumab injection (subcutaneous ) (Herceptin Hylecta) may be given with other drugs or after other drugs have been used to treat a certain type of breast cancer that has spread to other parts of the body. It is also used during and after treatment with other drugs to reduce the chance that a certain type of breast cancer will come back. That is, trastuzumab injection (subcutaneous injection ) is suitable for adjuvant treatment of HER2-overexpressing lymph node-positive or node-negative (ER/PR negative or with a high-risk feature); it is combined with paclitaxel (paclitaxel) for the first-line treatment of HER2-overexpressing metastatic breast cancer.

Trastuzumab injection (subcutaneous injection) contains trastuzumab and hyaluronidase. Hyaluronic acid is a polysaccharide found in the extracellular matrix of subcutaneous tissue. Its effect is reversible, and the permeability of subcutaneous tissue is restored within 24-48 hours. It has been proven that when used in the subcutaneous group of animal experiments When administered into tissues, the absorption rate of trastuzumab products into the systemic circulation can be increased, but its most common adverse reactions include fatigue, joint pain, diarrhea, injection site reactions, upper respiratory tract infection, rash, myalgia, nausea, headache, edema, flushing, fever, cough and pain in the extremities.

It is understood that the original drug of trastuzumab injection (subcutaneous injection) has been launched in China, but the specific price and other relevant information are not yet clear. Since the drug has been on the market for a short time, it has not been included in the scope of medical insurance. At present, there are no generic drugs of Trastuzumab injection (subcutaneous injection) produced and marketed. For more information and specific prices of Trastuzumab injection (subcutaneous injection), please consult a medical consultant.